Tenaya Therapeutics Inc (TNYA)
$0.66
$0.00
(-0.36%)
As on 09-Sep-2026 16:08EDT
Market cap
$153 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.7
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.5
-
Face value
--
-
Shares outstanding
224,230,012
5 Years Aggregate
CFO
$-326.85 Mln
EBITDA
$-373.66 Mln
Net Profit
$-381.49 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tenaya Therapeutics Inc (TNYA)
| -7.1 | -9.1 | -3.7 | -52.8 | -40.3 | -51.5 | -- |
|
BSE Sensex*
| -11.7 | -4.8 | 1.1 | -7.9 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Tenaya Therapeutics Inc (TNYA)
| -50.2 | -55.6 | 61.2 | -89.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tenaya Therapeutics Inc (TNYA)
|
0.7 | 153.2 | 1.3 | -103.1 | -7,724.0 | -107 | -- | 2.2 |
| 82.6 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 74.1 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 58.3 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 107.4 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 348.1 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 115.4 | 9,761.1 | 105.0 | -299.7 | -227.2 | -19.4 | -- | 6.5 | |
| 546.7 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 586.3 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 | |
| 124.0 | 9,808.7 | 0.0 | -450.1 | -- | -44.6 | -- | 8.4 |
Shareholding Pattern
View DetailsAbout Tenaya Therapeutics Inc (TNYA)
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated... hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. Read more
-
CEO, Secretary & Director
Mr. Faraz Ali M.B.A.
-
CEO, Secretary & Director
Mr. Faraz Ali M.B.A.
-
Headquarters
South San Francisco, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Tenaya Therapeutics Inc (TNYA)
What is the current share price of Tenaya Therapeutics Inc (TNYA) Today?
The share price of Tenaya Therapeutics Inc (TNYA) is $0.66 (NASDAQ) as of 09-Sep-2026 16:08 EDT. Tenaya Therapeutics Inc (TNYA) has given a return of -40.26% in the last 3 years.
What is the current PB & PE ratio of Tenaya Therapeutics Inc (TNYA)?
Since, TTM earnings of Tenaya Therapeutics Inc (TNYA) is negative, P/E ratio is not available.
The P/B ratio of Tenaya Therapeutics Inc (TNYA) is 2.24 times as on 04-Sep-2026, a 58 discount to its peers’ median range of 5.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.20 |
0.88 |
2024 |
-1.11 |
1.33 |
2023 |
-1.78 |
1.59 |
2022 |
-0.90 |
0.46 |
2021 |
-11.22 |
2.81 |
What is the 52 Week High and Low of Tenaya Therapeutics Inc (TNYA)?
The 52-week high and low of Tenaya Therapeutics Inc (TNYA) are Rs 2.35 and Rs 0.53 as of 10-Sep-2026.
What is the market cap of Tenaya Therapeutics Inc (TNYA)?
Tenaya Therapeutics Inc (TNYA) has a market capitalisation of $ 153 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Tenaya Therapeutics Inc (TNYA)?
Before investing in Tenaya Therapeutics Inc (TNYA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.